ACHV

Achieve Life Sciences (ACHV)

About Achieve Life Sciences (ACHV)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Details

Daily high

$4.53

Daily low

$4.34

Price at open

$4.47

52 Week High

$5.78

52 Week Low

$1.84

Market cap

239.0M

Dividend yield

0.00%

Volume

580,484

Avg. volume

615,284

P/E ratio

-3.26

Achieve Life Sciences News